[Botulinum toxin injection to the lateral rectus for the treatment of intractable diplopia].
The aim of the study is to evaluate the use of botuline A (BTXA) as a form of treatment for squinting patients with onerous diplopia. Two patients with exotropia and one patient with esotropia had injections of BTX A to the lateral rectus muscles of the affected side. The number of injections ranged from 1 to 2. Two patients went on to have surgery. All patients in our study found that BTX A improved their symptoms of diplopia. We conclude that BTX A has an important role in the treatment of squinting patients with burdensome diplopia.
Broniarczyk-Loba
Anna
A
Z Przyklinicznej Poradni Leczenia Zeza Kliniki Chorób Oczu Katedry Chorób Oczu Uniwersytetu Medycznego w Lodzi.
Laudańska-Olszewska
Iwona
I
Nowakowska
Olimpia
O
D000293:Adolescent; D000328:Adult; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D004172:Diplopia / Q000188:drug therapy*; D004948:Esotropia / Q000188:drug therapy*; D005099:Exotropia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A